Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Charles River Laboratories Intl
(NY:
CRL
)
223.15
-4.16 (-1.83%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
384,816
Open
226.55
Bid (Size)
215.00 (1)
Ask (Size)
232.81 (1)
Prev. Close
227.31
Today's Range
223.03 - 231.39
52wk Range
161.65 - 275.00
Shares Outstanding
50,396,622
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call
July 16, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Apple To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday
July 10, 2024
Via
Benzinga
Performance
YTD
-4.74%
-4.74%
1 Month
+7.07%
+7.07%
3 Month
-3.02%
-3.02%
6 Month
+9.65%
+9.65%
1 Year
+10.83%
+10.83%
More News
Read More
Charles River to Perform Plasmid Manufacturing for AAVantgarde
July 08, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
These Nike Analysts Are No Longer Bullish; Here Are Top 5 Downgrades For Friday
June 28, 2024
Via
Benzinga
Demystifying Charles River: Insights From 4 Analyst Reviews
June 28, 2024
Via
Benzinga
The Analyst Verdict: Charles River In The Eyes Of 4 Experts
June 06, 2024
Via
Benzinga
Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus
June 25, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy
June 17, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives
June 11, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
The Analyst Landscape: 7 Takes On Charles River
May 10, 2024
Via
Benzinga
Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville
June 06, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research
June 04, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories to Present at William Blair and Jefferies Conferences
June 03, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development
May 30, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
CRL Stock Earnings: Charles River Beats EPS, Beats Revenue for Q1 2024
May 09, 2024
Via
InvestorPlace
Charles River Laboratories Announces First-Quarter 2024 Results
May 09, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
The 7 Best Growth Stocks to Buy in May 2024
May 08, 2024
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
May 07, 2024
Via
Benzinga
Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP
May 02, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
April 22, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
April 16, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
April 12, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
April 11, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
April 09, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River to Perform Plasmid Production for Ship of Theseus
April 04, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.